Cspc Zhongnuo Pharmaceutical (shijiazhuang) Co., Ltd.
Clinical trials sponsored by Cspc Zhongnuo Pharmaceutical (shijiazhuang) Co., Ltd., explained in plain language.
-
New shot aims to tame stubborn cholesterol
Disease control CompletedThis study tested an experimental injection called SYH2053 to see if it could safely lower 'bad' cholesterol (LDL-C) in adults with high cholesterol. It involved 156 participants who received either the new injection, a placebo (dummy shot), or an existing cholesterol drug for co…
Phase: PHASE2 • Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New schizophrenia shot tested against established brand
Disease control CompletedThis study tested whether a new monthly injection for schizophrenia works the same way in the body as an existing, approved injection. It involved 256 adults in China with stable schizophrenia who received either the new or the existing injection for several months. The main goal…
Phase: NA • Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC